Skip to content

Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment

Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00772252
Enrollment
80
Registered
2008-10-15
Start date
2008-08-31
Completion date
2010-12-31
Last updated
2010-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Liver Failure

Keywords

Liver support treatment

Brief summary

Background: In patients undergoing hemodialysis or hemofiltration will suffer from the injury of reactive oxidative species. Oxidative stress will affect cell membrane, protein, and DNA. It will damage the cell and result in organ dysfunction. We believe that in patients, who have acute hepatic failure, undergoing plasma exchange or Molecular Absorbent Recirculating System for bridge therapy will suffer from the injury of reactive oxidative species, too. It will damage the kidney, lung, cerebral cortex, and other organs. It may result in death before the recovery of liver function or undergoing liver transplantation. Aims: 1. Investigate the severity of oxidative stress and risk factors of high oxidative stress in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 2. Investigate the microcirculation status and risk factors in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 3. Study the relationship between oxidative stress and microcirculation status. 4. Study the correlation between oxidative stress and prognosis. 5. Study the correlation between microcirculation status and prognosis.

Interventions

OTHERliver support treatment

plasma exchange for liver support treatment

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years old 2. Patients with acute deterioration on Chronic liver failure, who required liver support treamtment 3. Patients with acute liver failure due to acute hepatitis, who reauired liver support treatment 4. Patients with acute liver dysfunction within 7 days after liver transplantation, who required liver support treatment

Exclusion criteria

1. Age \> 70 years old 2. Cancer, not curable 3. Patients who had used of antioxidant therapy within 24 hours before study 4. Patients who had received hyperbaric oxygen therapy within 24 hours before study 5. Patients who had received peroxide treatment within 24 hours before study

Countries

Taiwan

Contacts

Primary ContactYu-Chang Yeh
tonyyeh@ntuh.gov.tw0968661829

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026